Central Nervous System Diseases
📧 Sign up to get email alerts when something new happens for Central Nervous System Diseases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide. [Phase 4]
A Phase 4 clinical trial is investigating the effectiveness and safety of butylphthalide for ischemic stroke patients; recruitment is ongoin…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Stimulation With Wire Leads to Restore Cough [NA]
A completed clinical trial investigated stimulation with wire leads as a potential approach to restore coughing in individuals with spinal c…
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Propranolol on Post Stroke Immune Status and Infection [Phase 2]
Phase 2 clinical trial investigating propranolol's effect on post-stroke immune status and infection risk.
-
CLINICAL_TRIALS trial_result · 2022-03-03Clinical Trial Update: Predictors of Response in Chronic Stroke [NA]
Clinical trial update on predictors of response in chronic stroke; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor [Phase 4]
Phase 4 trial investigating dexmedetomidine to prevent postoperative delirium after intracranial tumor surgery.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor [Phase 4]
A Phase 4 clinical trial evaluated the impact of dexmedetomidine on postoperative delirium in patients following intracranial surgery for br…
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: Sub-study to Spinal Cord Stimulation to Restore Cough [NA]
A completed clinical trial investigating sub-studies of spinal cord stimulation to restore cough function in individuals with spinal cord in…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients
A completed retrospective study evaluated MRI with MULTIHANCE at 0.10 and 0.05 mmol/kg in patients with central nervous system diseases, inc…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Clinical Evaluation of Swallowing Disorders as a Predictor of Extubation Failure
A completed clinical trial evaluating whether swallowing disorders can predict extubation failure in patients with central nervous system di…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions [Phase 3]
Phase 3 clinical trial update evaluating DOTAREM for MRI imaging of central nervous system lesions; study completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease [Phase 4]
Clinical trial NCT01662414, sponsored by Chulalongkorn University, evaluated HMS 90 undenatured cysteine-rich whey protein isolate in Parkin…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging [Phase 3]
Phase 3 study evaluating gadobutrol 1.0 mmol/mL (Gadavist) for central nervous system imaging reported safety and efficacy results. Results …
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients [Phase 3]
Phase 3 study evaluating Gadavist (gadobutrol) as an MRI contrast agent for brain or spine diseases in Chinese patients; the trial has compl…